P13K Inhibitor Archives

First P13K inhibitor for Breast Cancer Gets FDA Approved

by PEPID Newsroom | May 24, 2019 | Alerts

Pigray (alpelisib) tablets have been FDA approved to treat breast cancer in combination with FDA-approved endocrine therapy fulvestrant. Pigray is approved for postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2...

First P13K inhibitor for Breast Cancer Gets FDA Approved

Recent Posts

Categories